Frank Bymaster

1 Patent

• US120424812024

  Use of (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters

  OTSUKA AMERICA PHARMACEUTICAL, Inc.

  0 cites